Cocrystal Pharma, Inc. (COCP)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Cocrystal Pharma, Inc. (COCP)
Company Performance

Current Price

as of Oct 16, 2024

$2.20

P/E Ratio

N/A

Market Cap

$22.38M

Description

Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.

Metrics

Overview

  • HQBothell, WA
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • TickerCOCP
  • Price$2.2+20.05%

Trading Information

  • Market Cap$22.38M
  • Float68.33%
  • Average Daily Volume (1m)18,330
  • Average Daily Volume (3m)18,140
  • EPS-$1.76

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$5.34M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$5.42M
  • EV$7.27M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.29
Documents